Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.9995T>G | p.Phe3332Cys | Hemizygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
TTT | Phe | TGT | Cys | T->G | Tv |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
Carboxy-terminal region | Yes, coding strand | No |
At the mRNA level | On restriction map |
New restriction site(s): none Lost restriction site(s): Mse I |
Pathogenicity (bioinformatics predictions) | ||
Conservation (0-1) | SIFT (0-1) | UMD predictor (0-100) |
0 | - | 71 (Probably pathogenous) |
On isoforms (a blue cell indicates that the corresponding isoform is affected by the mutation) | ||||||
Dp 427c | Dp 427m | Dp 427p | Dp 260 | Dp 140 | Dp 116 | Dp 71 |
Immunofluorescence | ||
dys 1 | dys 2 | dys 3 |
Western Blot | ||
dys 1 | dys 2 | dys 3 |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
---264-6-01 | Proband | Male | De novo | FRANCE |
Phenotypic group |
DMD |
Patient also carries the Cys3340Arg mutation |
Reference ID | Reference |
106 | Unpublished data |